Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Peripheral Arterial Disease (PAD) Therapeutics
... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% ... Read More
-
Global Antacids Market Report by Formulation Type (Powder, Tablets, Liquid, Others) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Drug Class (Acid Neutralizers, Proton Pump Inhibitors, H2 Antagonist, Pro-Motility Agents) Countries and Company Analysis, 2024-2032
... Global Antacids Market Size Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence ... Read More
-
Epigenetics
... of 13.3% over the analysis period 2023-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Women's Health Therapeutics
... Billion by 2030, growing at a CAGR of 12.7% over the analysis period 2023-2030. Postmenopausal Osteoporosis Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$18.1 ... Read More
-
Lung Cancer Therapeutics
... by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach ... Read More
-
Botulinum Toxin
... at a CAGR of 8.8% over the analysis period 2023-2030. Type A Botulinum Toxin, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$11.0 Billion by the ... Read More
-
Global AI in Drug Discovery Market 2024-2031
... and others), by Application (Drug Optimization and Repurposing, Preclinical Testing and Drug Screening) and by End-Users (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Research Centers and Academic & Government Institutes), Forecast Period (2024-2031) ... Read More
-
Metabolomics
... of 14.4% over the analysis period 2023-2030. Biomarker Discovery Application, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Enzyme Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Enzymes [Pharmaceutical Manufacturing, Diagnostic, Research And Development, And Others]) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the growing pharmaceutical and healthcare sector and the product development activities ... Read More
-
Ophthalmic Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Drug Class (Anti-Allergic, Anti-Inflammatory, Anti-Vegf Agents, And Others), By Dosage Forms (Gels, Capsules/Tablets, Eye Drops, And Others), and by geography is expected to advance at a respectable cagr forecast till 2030 owing to the rising ... Read More
-
Keratoconus - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Keratoconus: Understanding ... Read More
-
Hair Loss Treatment & Removal in the US - Industry Market Research Report
... treatments that address many hair-care needs. Over the past five years, the industry has experienced strong growth due to the increasing popularity of industry services. In fact, industry revenue has been increasing at a CAGR ... Read More
-
Metabolomics Market (Product and Service Type: Metabolomic Instruments, and Bioinformatics Tools and Services; and Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Personalized Medicine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Forecast, 2024-2034 Metabolomics Market – Scope of Report TMR’s report on the global metabolomics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of ... Read More
-
Europe Synthetic Hormones Market: Focus on Product Type, Route of Administration, Application, End User, and Country - Analysis and Forecast, 2023-2033
... at $4.90 billion in 2023 and is expected to reach $10.53 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2023-2033. The synthetic hormones market is advancing due to significant developments ... Read More
-
Europe Highly Potent API Market - Analysis and Forecast, 2023-2033
... 2023, growing at a CAGR of 10.57% during the forecast period 2023-2033. The primary factors propelling the expansion of the highly potent API market are the rising incidence of cancer, which boosts the demand for ... Read More
-
Prurigo Nodularis: Competitive Landscape
... PN are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast for PN. There is only a single disease-modifying innovator therapy available in the market for PN. The PN pipeline comprises 20 molecules, with ... Read More
-
Female Infertility: Seven-Market Drug Forecast and Market Analysis
... estimates that the value of the female infertility market in the 7MM in 2023 was $1.6 billion. This market is defined as sales of the major drugs and most commonly prescribed off-label treatments for female ... Read More
-
Female Infertility: Epidemiology Forecast to 2033
... et al., 2009; Mascarenhas et al., 2012; Mayo Clinic, 2021; World Health Organization, 2024). Infertility affects millions of people and has an impact on their families and communities. Estimates suggest that approximately one in every ... Read More
-
Osteoporosis: Seven-Market Drug Forecast and Market Analysis
... as a systemic skeletal disease characterized by low bone mass and micro-architectural deterioration of bone tissue, predisposing a person to bone fragility and susceptibility to fracture. Common sites of fracture include the spine, hip, distal ... Read More
-
AI In Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Hardware, Software, Services), By Technology (Machine Learning {Deep Learning, Supervised Learning, Unsupervised Learning, Others}, Computer Vision), By Functionality (Genome Sequencing, Gene Editing, Others), By Application (Drug Discovery & Development, Precision Medicine, Diagnostics, Others), By End Use (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Others), By Region and Competition, 2019-2029F
... Sequencing, Gene Editing, Others), By Application (Drug Discovery & Development, Precision Medicine, Diagnostics, Others), By End Use (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Others), By Region and Competition, 2019-2029F Global AI In Genomics ... Read More
-
Metabolomics: Technologies and Global Markets
... 32 data tables and 39 additional tables An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms Analysis of global market trends, featuring ... Read More
-
Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis
... through 2033. GlobalData estimates the sales of CKD therapeutics to be approximately $2.2 billion across the 7MM in 2023. By 2033, GlobalData expects the CKD market to grow at a strong compound annual growth rate ... Read More
-
Multiple Sclerosis Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... USD 35.16 billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029). The global multiple sclerosis therapeutics market size is expected to grow from USD 30.03 billion in 2023 to USD ... Read More
-
Niemann Pick Type C: Opportunity Assessment and Forecast - Update
... AGR of 0.29%. Currently, the treatment regimen for NPC in the 3MM is entirely limited to the use of miglustat (Yargesa, Zavesca or generic). There are several unmet needs in this space, including therapies with ... Read More
-
Global Therapeutics Market (2024 Edition): Analysis By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area, By Region, By Country: Market Insights and Forecast (2020-2030)
... titled Global Therapeutics Market (2024 Edition) which provides a complete analysis of the Global Therapeutics industry in terms of market segmentation By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area (Oncology, Infectious Disease, ... Read More